BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15963857)

  • 1. Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
    Niiya H; Sakai I; Lei J; Azuma T; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
    Exp Hematol; 2005 Jul; 33(7):811-8. PubMed ID: 15963857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
    J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    Lichtenheld MG; Podack ER; Levy RB
    J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones.
    Strack P; Martin C; Saito S; Dekruyff RH; Ju ST
    Eur J Immunol; 1990 Jan; 20(1):179-84. PubMed ID: 1968392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
    J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones.
    Yasukawa M; Yakushijin Y; Hasegawa H; Miyake M; Hitsumoto Y; Kimura S; Takeuchi N; Fujita S
    Blood; 1993 Mar; 81(6):1527-34. PubMed ID: 8095828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
    Yasukawa M; Inatsuki A; Kobayashi Y
    J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica.
    Ambach A; Bonnekoh B; Gollnick H
    J Allergy Clin Immunol; 2001 May; 107(5):878-86. PubMed ID: 11344356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
    Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
    J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease.
    Müller S; Lory J; Corazza N; Griffiths GM; Z'graggen K; Mazzucchelli L; Kappeler A; Mueller C
    Am J Pathol; 1998 Jan; 152(1):261-8. PubMed ID: 9422543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
    Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
    Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ CTLs are essential for protective immunity against Encephalitozoon cuniculi infection.
    Khan IA; Schwartzman JD; Kasper LH; Moretto M
    J Immunol; 1999 May; 162(10):6086-91. PubMed ID: 10229850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction by concanavalin A of specific mRNAs and cytolytic function in a CD8-positive T cell hybridoma.
    Gu JJ; Harriss JV; Ozato K; Gottlieb PD
    J Immunol; 1994 Nov; 153(10):4408-17. PubMed ID: 7963518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytes and perforin expression in endometrium during the menstrual cycle.
    Tian X; Zhang L; Zhang X
    Chin Med J (Engl); 2000 Oct; 113(10):930-3. PubMed ID: 11775843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.
    Kuechler PC; Britschgi M; Schmid S; Hari Y; Grabscheid B; Pichler WJ
    Allergy; 2004 Jun; 59(6):613-22. PubMed ID: 15147446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.